Revance Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $734k | 84k | 8.79 |
| 2023-09-30 | $955k | 83k | 11.47 |
| 2023-06-30 | $2.0M | 78k | 25.31 |
| 2023-03-31 | $1.4M | 42k | 32.21 |
| 2022-12-31 | $641k | 35k | 18.46 |
| 2022-09-30 | $891k | 33k | 26.99 |
| 2022-06-30 | $575k | 42k | 13.81 |
| 2022-03-31 | $817k | 42k | 19.49 |
| 2021-12-31 | $674k | 41k | 16.30 |
| 2021-09-30 | $889k | 32k | 27.61 |
| 2021-06-30 | $560k | 19k | 29.67 |
| 2021-03-31 | $510k | 18k | 27.93 |
| 2020-12-31 | $483k | 17k | 28.27 |
| 2020-09-30 | $456k | 18k | 25.19 |
| 2020-06-30 | $485k | 20k | 24.43 |
| 2020-03-31 | $283k | 19k | 14.86 |
| 2019-12-31 | $298k | 18k | 16.25 |
| 2019-09-30 | $130k | 10k | 13.00 |
| 2019-06-30 | $112k | 8.6k | 13.00 |
| 2019-03-31 | $121k | 7.6k | 15.84 |
| 2018-12-31 | $130k | 6.4k | 20.16 |
| 2018-09-30 | $131k | 5.3k | 24.79 |
| 2018-06-30 | $145k | 5.3k | 27.45 |
| 2018-03-31 | $159k | 5.2k | 30.71 |
| 2017-12-31 | $208k | 5.8k | 35.77 |
| 2017-09-30 | $160k | 5.8k | 27.63 |
| 2017-06-30 | $153k | 5.8k | 26.37 |
| 2017-03-31 | $111k | 5.4k | 20.72 |
| 2016-12-31 | $112k | 5.4k | 20.64 |
| 2016-09-30 | $58k | 3.6k | 16.29 |
| 2016-06-30 | $49k | 3.6k | 13.76 |
| 2016-03-31 | $63k | 3.6k | 17.69 |
| 2015-12-31 | $91k | 2.6k | 35.53 |
| 2015-09-30 | $73k | 2.6k | 28.50 |
| 2015-06-30 | $58k | 1.8k | 32.44 |
| 2015-03-31 | $19k | 953 | 19.94 |
| 2014-12-31 | $16k | 953 | 16.79 |
| 2014-09-30 | $19k | 953 | 19.94 |